SARTORIUS AG UNSP.ADR 1/5 - Asset Resilience Ratio
SARTORIUS AG UNSP.ADR 1/5 (SRT4) has an Asset Resilience Ratio of 0.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how SARTORIUS AG UNSP.ADR 1/5's Asset Resilience Ratio has changed over time. See how financially flexible is SARTORIUS AG UNSP.ADR 1/5 to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down SARTORIUS AG UNSP.ADR 1/5's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SRT4 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.10 Million | 0.26% |
| Total Liquid Assets | €26.10 Million | 0.26% |
Asset Resilience Insights
- Limited Liquidity: SARTORIUS AG UNSP.ADR 1/5 maintains only 0.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SARTORIUS AG UNSP.ADR 1/5 Industry Peers by Asset Resilience Ratio
Compare SARTORIUS AG UNSP.ADR 1/5's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 4.32% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for SARTORIUS AG UNSP.ADR 1/5 (2021–2025)
The table below shows the annual Asset Resilience Ratio data for SARTORIUS AG UNSP.ADR 1/5.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | €10.40 Million ≈ $12.16 Million |
€9.72 Billion ≈ $11.36 Billion |
-0.04pp |
| 2024-12-31 | 0.15% | €15.30 Million ≈ $17.89 Million |
€10.10 Billion ≈ $11.81 Billion |
0.00pp |
| 2023-12-31 | 0.15% | €15.00 Million ≈ $17.54 Million |
€9.75 Billion ≈ $11.39 Billion |
-0.29pp |
| 2022-12-31 | 0.44% | €30.90 Million ≈ $36.13 Million |
€6.98 Billion ≈ $8.16 Billion |
+0.12pp |
| 2021-12-31 | 0.32% | €18.20 Million ≈ $21.28 Million |
€5.70 Billion ≈ $6.66 Billion |
-- |
About SARTORIUS AG UNSP.ADR 1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more